Skip to main content
. 2018 Aug 27;62(9):e01016-18. doi: 10.1128/AAC.01016-18

TABLE 1.

Bacterial susceptibility profile of NOSO-502 against reference bacterial strainsa

Strain MIC (μg/ml) of antibiotic
NOS CIP GEN IPM TGC PMB
Citrobacter freundii DSM 30039 2 ≤0.125 0.5 1 1 0.5
Citrobacter kozeri DSM 4595 2 ≤0.125 0.25 4 1 0.25
Enterobacter aerogenes DSM 30053 2 ≤0.125 0.25 2 1 0.5
Enterobacter cloacae DSM 14563 2 ≤0.125 0.5 1 4 1
Escherichia coli ATCC 25922 4 ≤0.125 1 0.25 0.25 0.5
Klebsiella pneumoniae ATCC 43816 1 ≤0.125 0.25 1 2 1
Serratia marcescens DSM 17174 4 ≤0.125 0.5 2 4 >32
Acinetobacter baumannii ATCC 19606 >64 2 16 0.5 1 0.5
Pseudomonas aeruginosa DSM 1117 >64 1 1 2 >8 1
Stenotrophomonas maltophilia ATCC 13637 16 1 4 >64 0.5 1
Enterococcus faecalis DSM 2570 >64 2 16 1 0.25 >32
Enterococcus faecium DSM 20477 64 16 8 4 0.125 >32
Staphylococcus aureus ATCC 29213 1 0.25 0.5 ≤0.125 0.5 16
Staphylococcus epidermidis ATCC 12228 0.25 0.25 ≤0.125 ≤0.125 0.5 16
Streptococcus pneumoniae DSM 2134 64 1 8 ≤0.125 0.125 >32
a

NOS, NOSO-502; CIP, ciprofloxacin; GEN, gentamicin; PMB, polymyxin B; IPM, imipenem; TGC, tigecycline.